The CardioMetabolic Health Alliance
Open accessAbstract
The Cardiometabolic Think Tank was convened on June 20, 2014, in Washington, DC, as a "call to action" activity focused on defining new patient care models and approaches to address contemporary issues of cardiometabolic risk and disease. Individual experts representing >20 professional organizations participated in this roundtable discussion. The Think Tank consensus was that the metabolic syndrome (MetS) is a complex pathophysiological state comprised of a cluster of clinically measured and typically unmeasured risk factors, is progressive in its course, and is associated with serious and extensive comorbidity, but tends to be clinically under-recognized. The ideal patient care model for MetS must accurately identify those at risk before MetS develops and must recognize subtypes and stages of MetS to more effectively direct prevention and therapies. This new MetS care model introduces both affirmed and emerging concepts that will require consensus development, validation, and optimization in the future.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 81 cited sources checked · 0 supported · 0 flagged
- Interpretationcitation
Lifestyle, referring to physical activity and nutrition, is a modifiable factor crucial to prevent and treat MetS and its consequences.
“The TT recognized lifestyle, referring to physical activity and nutrition, as being a modifiable factor crucial to prevent and treat MetS and its consequences.”
Quote in the paperSubstantial claim - Interpretationreasoning
The current definition of MetS does not account for susceptibility for a given degree of adiposity.
“nor does it account for susceptibility for a given degree of adiposity, as noted earlier.”
Quote in the paperSubstantial claim - Premisecitation
Waist circumference appeared to be a better predictor of total body fat than BMI.
“waist circumference appeared to be a better predictor of total body fat than BMI (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Vega, 2006, Influence of body fat content and distribution on variation in metabolic risk, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Excess truncal fat further increased risk after adjusting for total body fat.
“Excess truncal fat further increased risk after adjusting for total body fat.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Vega, 2006, Influence of body fat content and distribution on variation in metabolic risk, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Malay women with MetS had different factor patterns with greater importance of hypertension, insulin resistance, and triglycerides when compared with other South Asian women.
“For example, Malay women with MetS had different factor patterns with greater importance of hypertension, insulin resistance, and triglycerides when compared with other South Asian women (7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Ang, 2005, The metabolic syndrome in Chinese, Malays, and Asian Indians. Factor analysis of data from the 1998 Singapore National Health Survey, Diabetes Res Clin Pract
Not checked in the free run.
- Premisecitation
ASCVD risk is higher with MetS in the absence of T2D compared with T2D without MetS (13.9% vs. 7.5%).
“ASCVD risk is higher with MetS in the absence of T2D compared with T2D without MetS (13.9% vs. 7.5%, respectively) (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Alexander, 2003, NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 and older, Diabetes source
Not checked in the free run.
- Premisecitation
Differences in risk factor burden early in life translate into marked differences in the risk of adverse health outcomes later in life.
“This is critical because differences in risk factor burden early in life translate into marked differences in the risk of adverse health outcomes later in life (64).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] Berry, 2012, Lifetime risks of cardiovascular disease, N Engl J Med source
Not checked in the free run.
- Premisecitation
Excess intra-abdominal (i.e., visceral) adipose tissue may be a primary driver of the cardiometabolic complications of obesity.
“Excess intra-abdominal (i.e., visceral) adipose tissue may be a primary driver of the cardiometabolic complications of obesity (43)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Després, 2008, Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk, Arterioscler Thromb Vasc Biol source
Not checked in the free run.
- Premisecitation
In the Hoorn study in the Netherlands, the risk of cardiovascular outcomes rose rapidly with an increasing number of MetS components, becoming statistically significant at 3 factors for men and 2 factors for women.
“In the Hoorn study in the Netherlands, the risk of cardiovascular outcomes rose rapidly with an increasing number of MetS components, becoming statistically significant at $3 factors for men and $2 factors for women (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Girman, 2005, An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study, Am J Epidemiol source
Not checked in the free run.
- Premisecitation
MetS is a clinical entity associated with an increased risk of ASCVD or death, even after controlling for its component risk factors (risk ratio: 1.54; 95% confidence interval: 1.32 to 1.79).
“It is imperative to recognize that MetS is not just a repackaging of its individual risk components, but, as demonstrated in at least 1 analysis, is a clinical entity associated with an increased risk of ASCVD or death, even after controlling for its component risk factors (risk ratio: 1.54; 95% confidence interval: 1.32 to 1.79) (39).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Gami, 2007, Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies, J Am Coll Cardiol source
Not checked in the free run.
- Interpretationreasoning
Age, race, and sex contribute to metabolic susceptibility, in part mediated by differences in adipose tissue distribution and adipocyte size and function.
“Age, race, and sex also contribute to metabolic susceptibility, in part mediated by differences in adipose tissue distribution and adipocyte size and function.”
Quote in the paperSubstantial claim - Interpretationreasoning
Racial phenotypic variability of MetS is not well captured by standard MetS paradigms.
“These findings highlight the racial phenotypic variability of MetS that is not well captured by standard MetS paradigms.”
Quote in the paperSubstantial claim - Premisecitation
Multiple factors that begin before birth and continue through delivery, such as low birth weight, small head circumference, gestational diabetes, and lack of breastfeeding, place children at risk for MetS in adolescence and adulthood.
“For example, multiple factors that begin before birth and continue through delivery, such as low birth weight, small head circumference, gestational diabetes, and lack of breastfeeding, place children at risk for MetS in adolescence and adulthood (65).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] Efstathiou, 2012, Metabolic syndrome in adolescence: can it be predicted from natal and parental profile? The Prediction of Metabolic Syndrome in Adolescence (PREMA) study, Circulation source
Not checked in the free run.
- Interpretationcitation
MetS tends to be clinically under-recognized.
“but tends to be clinically under-recognized”
- Also stated in: § METHODS · boosted
“The importance of MetS in cardiometabolic risk remains widely under-recognized, as highlighted by the fact that several of the most recent professional society guidelines on heart disease and stroke prevention give little or no attention to its role in disease prevention (28)(29)(30)(31).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [28] Eckel, 2014, 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol source
Not checked in the free run.
- cites [29] Goff, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol source
Not checked in the free run.
- cites [30] Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol source
Not checked in the free run.
- Also stated in: § METHODS · boosted
- Premisecitation
An increase in VAT is thought to reflect the relative inability of the subcutaneous adipose tissue depot to sufficiently expand its clearance and storage capacity in response to caloric excess.
“An increase in VAT is thought to reflect the relative inability of the subcutaneous adipose tissue depot to sufficiently expand its clearance and storage capacity in response to caloric excess (44).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] McLaughlin, 2011, Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity, J Clin Endocrinol Metab source
Not checked in the free run.
- Interpretationnone given
The current definition of MetS does not accurately assess ASCVD risk.
“but does not accurately assess that risk”
Quote in the paperNot a substantial claim - Premisecitation
Lower body subcutaneous fat was protective.
“Conversely, lower body subcutaneous fat was protective”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Vega, 2006, Influence of body fat content and distribution on variation in metabolic risk, J Clin Endocrinol Metab source
Not checked in the free run.
- Interpretationcitation
MetS is not just a repackaging of its individual risk components.
“It is imperative to recognize that MetS is not just a repackaging of its individual risk components”
Quote in the paperSubstantial claim - Interpretationnone given
Risk for MetS varies substantially by distribution of both adipocyte and nonadipocyte (ectopic) fat, as well as by adipocyte size and function.
“Rather, it appears that risk for MetS varies substantially by distribution of both adipocyte and nonadipocyte (ectopic) fat, as well as by adipocyte size and function.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Using a combination of BMI and waist circumference in MetS risk assessment may prove better than either measure alone.
“Given these findings, using a combination of BMI and waist circumference in MetS risk assessment may prove better than either measure alone (22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Cerhan, 2014, A pooled analysis of waist circumference and mortality in 650,000 adults, Mayo Clin Proc source
Not checked in the free run.
- Interpretationcitation
ASCVD risk rises exponentially as the number of MetS elements increases.
“Additionally, ASCVD risk rises exponentially as the number of MetS elements increases.”
Quote in the paperSubstantial claim - Premisecitation
MetS is associated with a >2-fold increased risk for ASCVD and cardiovascular mortality, based on a meta-analysis of 87 studies with 951,083 patients.
“A meta-analysis, including 87 studies with 951,083 patients, demonstrated that MetS was associated with a >2-fold increased risk for ASCVD and cardiovascular mortality (9).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Mottillo, 2010, The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Visceral adipose tissue (VAT) appears to be associated with dyslipidemia and atherosclerosis, regardless of sex or race.
“Visceral adipose tissue (VAT) appears to be associated with dyslipidemia and atherosclerosis, regardless of sex or race (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Neeland, 2013, Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults, Obesity (Silver Spring) source
Not checked in the free run.
- Premisecitation
In the Dallas Heart Study, total body fat correlated with multiple metabolic risk factors, including insulin resistance.
“In the Dallas Heart Study, total body fat correlated with multiple metabolic risk factors, including insulin resistance.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Vega, 2006, Influence of body fat content and distribution on variation in metabolic risk, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Adipocyte size and lack of hyperplasia is associated with adipose tissue dysfunction, inflammatory markers, and insulin resistance.
“Finally, adipocyte size and lack of hyperplasia is associated with adipose tissue dysfunction, inflammatory markers, and insulin resistance (20,21).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [20] McLaughlin, 2010, Inflammation in subcutaneous adipose tissue: relationship to adipose cell size, Diabetologia source
Not checked in the free run.
- cites [21] McLaughlin, 2007, Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis, Diabetologia source
Not checked in the free run.
- Interpretationcitation
There is a limited evidence base for addressing disparities.
“There is also a limited evidence base for addressing disparities.”
Quote in the paperSubstantial claim - Premisecitation
The prevalence of MetS increases dramatically with increasing obesity.
“The prevalence of MetS increases dramatically with increasing obesity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Ervin, 2009, Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006, Natl Stat Health Report
Not checked in the free run.
- Interpretationreasoning
The ACO is another mechanism relevant to implementing a new MetS care model.
“The ACO is another mechanism relevant to implementing a new MetS care model.”
Quote in the paperNot a substantial claim- Rests on an assumption: The ACO is a larger organization than the PCMH that includes hospitals and specialty care.
- Rests on an assumption: Compared with many PCMH models, the ACO's reimbursement changes and cost-saving goals are more explicit and are better aligned to facilitate coordinated care.
- Premisecitation
Even in the presence of MetS, increased physical activity is associated with a substantially lower risk of ASCVD.
“Even in the presence of MetS, increased physical activity is associated with a substantially lower risk of ASCVD (68).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Broekhuizen, 2011, Physical activity, metabolic syndrome, and coronary risk: the Epic-Norfolk prospective population study, Eur J Cardiovasc Prev Rehabil source
Not checked in the free run.
- Premisecitation
Most studies have not demonstrated overall short-term cost savings of PCMH strategies.
“do not specifically address the effectiveness of these strategies, nor have most studies demonstrated overall short-term cost savings (100).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Edwards, 2014, Structuring payment to medical homes after the Affordable Care Act, J Gen Intern Med source
Not checked in the free run.
- Premisecitation
In 2009, several major organizations released a statement harmonizing the criteria for MetS, which is in use today.
“In 2009, several major organizations released a statement harmonizing the criteria for MetS, which is in use today (38).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Alberti, 2009, Circulation source
Not checked in the free run.
- Premisecitation
Araneta et al. piloted a 12-week Zumba fitness program in sedentary obese women with ≥2 MetS criteria (77% ethnic minorities), demonstrating significant blood pressure and fasting triglyceride reductions among the participants.
“Araneta et al. (92) piloted a 12-week Zumba fitness program in sedentary obese women with $2 MetS criteria (77% ethnic minorities), demonstrating significant blood pressure and fasting triglyceride reductions among the participants.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [92] Araneta, 2014, Benefits of Zumba fitness among sedentary adults with components of the metabolic syndrome: a pilot study, J Sports Med Phys Fitness
Not checked in the free run.
- Premisecitation
Available evaluations indicate that health care spending has declined in ACO models.
“Most ACO models are very new, but available evaluations indicate that health care spending has declined.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [103] McWilliams, 2013, Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract, JAMA source
Not checked in the free run.
- cites [104] Colla, 2012, Spending differences associated with the Medicare Physician Group Practice Demonstration, JAMA source
Not checked in the free run.
- cites [105] Centers for Medicare & Medicaid Services. Pioneer accountable care organizations succeed in improving care, lowering costs. July 16, 2013. Available at: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2013-Press-Releases-Items/2013-07-16.html. Accessed June 30, 2015.
Not checked in the free run.
- Premisecitation
A 48-week randomized controlled trial comparing restorative yoga to active stretching among adults with MetS found significantly lower fasting glucose in the yoga group at 12 months.
“The investigators also conducted a 48-week randomized controlled trial comparing restorative yoga to active stretching among adults with MetS, finding significantly lower fasting glucose in the yoga group at 12 months (93).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Kanaya, 2014, Restorative yoga and metabolic risk factors: The Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) randomized trial, J Diabetes source
Not checked in the free run.
- Premisecitation
In the same retrospective cohort study, African-American patients were less likely to meet blood pressure targets than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities.
“In fact, in a retrospective cohort study of 1,457 diabetic patients receiving care in a PCMH academic practice, African-American patients were less likely to receive HbA 1c testing or influenza vaccination or to meet LDL or blood pressure targets than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities (102).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [102] Simonetti, 2014, Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home, Diabetes Care source
Not checked in the free run.
- Interpretationcitation
Appropriate nutritional choices can modify the risk of cardiometabolic disease.
“Appropriate nutritional choices can also modify the risk of cardiometabolic disease.”
Quote in the paperSubstantial claim - Premisecitation
In the same retrospective cohort study, African-American patients were less likely to meet LDL targets than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities.
“In fact, in a retrospective cohort study of 1,457 diabetic patients receiving care in a PCMH academic practice, African-American patients were less likely to receive HbA 1c testing or influenza vaccination or to meet LDL or blood pressure targets than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities (102).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [102] Simonetti, 2014, Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home, Diabetes Care source
Not checked in the free run.
- Premisecitation
Current guidelines do not recognize racial-specific differences in lipid levels between Caucasian and African-American populations.
“For example, current guidelines do not recognize racial-specific differences in lipid levels between Caucasian and African-American populations(30).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
A systematic review of randomized controlled trials on worksite wellness programs demonstrated a statistically significant 3-lb weight reduction and 0.5 kg/m2 BMI reduction over 6 to 12 months.
“A systematic review of randomized controlled trials on worksite wellness programs demonstrated a statistically significant 3-lb weight reduction and 0.5 kg/m 2 BMI reduction over 6 to 12 months (81).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Anderson, 2009, The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity: a systematic review, Am J Prev Med source
Not checked in the free run.
- Premisecitation
In the same retrospective cohort study, African-American patients were less likely to receive influenza vaccination than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities.
“In fact, in a retrospective cohort study of 1,457 diabetic patients receiving care in a PCMH academic practice, African-American patients were less likely to receive HbA 1c testing or influenza vaccination or to meet LDL or blood pressure targets than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities (102).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [102] Simonetti, 2014, Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home, Diabetes Care source
Not checked in the free run.
- Premisecitation
A recent review of 27 PCMH studies found that only 11 provided any detail on their financial models.
“A recent review of 27 PCMH studies found that only 11 provided any detail on their financial models (101).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Williams, 2012
Not checked in the free run.
- Premisecitation
In a retrospective cohort study of 1,457 diabetic patients receiving care in a PCMH academic practice, African-American patients were less likely to receive HbA1c testing than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities.
“In fact, in a retrospective cohort study of 1,457 diabetic patients receiving care in a PCMH academic practice, African-American patients were less likely to receive HbA 1c testing or influenza vaccination or to meet LDL or blood pressure targets than non-Hispanic Caucasians, after adjusting for multiple demographic factors and comorbidities (102).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [102] Simonetti, 2014, Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home, Diabetes Care source
Not checked in the free run.
- Premisecitation
According to the same Centers for Medicare & Medicaid Services release of 1-year data, ACOs have better assessed LDL in patients with T2D.
“According to a Centers for Medicare & Medicaid Services release of 1-year data, ACOs have also slowed cost growth (0.3% vs. 0.8% in 2012), reduced readmission rates, improved blood pressure control, and better assessed LDL in patients with T2D (105).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Centers for Medicare & Medicaid Services. Pioneer accountable care organizations succeed in improving care, lowering costs. July 16, 2013. Available at: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2013-Press-Releases-Items/2013-07-16.html. Accessed June 30, 2015.
Not checked in the free run.
- Premisecitation
According to the same Centers for Medicare & Medicaid Services release of 1-year data, ACOs have reduced readmission rates.
“According to a Centers for Medicare & Medicaid Services release of 1-year data, ACOs have also slowed cost growth (0.3% vs. 0.8% in 2012), reduced readmission rates, improved blood pressure control, and better assessed LDL in patients with T2D (105).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Centers for Medicare & Medicaid Services. Pioneer accountable care organizations succeed in improving care, lowering costs. July 16, 2013. Available at: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2013-Press-Releases-Items/2013-07-16.html. Accessed June 30, 2015.
Not checked in the free run.
- Premisecitation
ACOs have successfully implemented quality improvement initiatives, as demonstrated by 1 evaluation in 11 primary care clinics that employed care coordination, a care gap summary tool, staff education, and workflow redesign.
“In addition to cost savings, ACOs have successfully implemented quality improvement initiatives, as demonstrated by 1 evaluation in 11 primary care clinics that employed care coordination, a care gap summary tool, staff education, and workflow redesign (106).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] Wilkinson, 2013, Promoting preventive health screening through the use of a clinical reminder tool: an accountable care organization quality improvement initiative, J Healthc Qual source
Not checked in the free run.
- Premisecitation
According to a Centers for Medicare & Medicaid Services release of 1-year data, ACOs have slowed cost growth (0.3% vs. 0.8% in 2012).
“According to a Centers for Medicare & Medicaid Services release of 1-year data, ACOs have also slowed cost growth (0.3% vs. 0.8% in 2012), reduced readmission rates, improved blood pressure control, and better assessed LDL in patients with T2D (105).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Centers for Medicare & Medicaid Services. Pioneer accountable care organizations succeed in improving care, lowering costs. July 16, 2013. Available at: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2013-Press-Releases-Items/2013-07-16.html. Accessed June 30, 2015.
Not checked in the free run.
- Premisecitation
According to the same Centers for Medicare & Medicaid Services release of 1-year data, ACOs have improved blood pressure control.
“According to a Centers for Medicare & Medicaid Services release of 1-year data, ACOs have also slowed cost growth (0.3% vs. 0.8% in 2012), reduced readmission rates, improved blood pressure control, and better assessed LDL in patients with T2D (105).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Centers for Medicare & Medicaid Services. Pioneer accountable care organizations succeed in improving care, lowering costs. July 16, 2013. Available at: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2013-Press-Releases-Items/2013-07-16.html. Accessed June 30, 2015.
Not checked in the free run.
- May combine two claims. 39
- Classified as probably not a substantial claim. 20
- The quote only partly states this claim. 2
May combine two claims.
PremisecitationFactor analysis in epidemiological studies in different populations, including adolescents and ethnic minorities, demonstrates clustering of risk in the domains of adiposity and/or dyslipidemia, hyperglycemia or insulin resistance, and hypertension that explain 37% to 70% of variation and vary by sex and race.
“Factor analysis in epidemiological studies in different populations, including adolescents and ethnic minorities, demonstrates clustering of risk in the domains of adiposity and/or dyslipidemia, hyperglycemia or insulin resistance, and hypertension that explain 37% to 70% of variation and vary by sex and race (4-7).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [4] Goodman, 2005, Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth, Circulation source
Not checked in the free run.
- cites [5] Hanley, 2002, Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study, Diabetes source
Not checked in the free run.
- cites [6] Hodge, 2001, Leptin and other components of the Metabolic Syndrome in Mauritius—a factor analysis, Int J Obes Relat Metab Disord source
Not checked in the free run.
- cites [7] Ang, 2005, The metabolic syndrome in Chinese, Malays, and Asian Indians. Factor analysis of data from the 1998 Singapore National Health Survey, Diabetes Res Clin Pract
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenMetabolic syndrome (MetS) is a complex pathophysiological state comprising a cluster of clinically measured and typically unmeasured risk factors.
“The Think Tank consensus was that the metabolic syndrome (MetS) is a complex pathophysiological state comprised of a cluster of clinically measured and typically unmeasured risk factors”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenRisk for adverse health outcomes increases substantially with accumulation of component MetS risk factors, in addition to unmeasured residual risk factors.
“AC.3.Risk for adverse health outcomes increases substantially with accumulation of component MetS risk factors, in addition to unmeasured (”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenPeople with MetS have or are at risk for multi-end-organ damage.
“Another concept essential to the MetS definition is that people with MetS have or are at risk for multi-end-organ damage.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningObesity per se, as defined by simple anthropometric measures such as BMI or waist circumference, is neither a necessary nor a sufficient descriptor of MetS and its consequences.
“However, there is a growing appreciation that obesity per se, as defined by simple anthropometric measures, such as BMI or waist circumference, is neither a necessary nor a sufficient descriptor of MetS and its consequences.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMetS is present in approximately 50% of patients with diagnosed vascular disease and may be even more prevalent among women with ASCVD.
“MetS is present in w50% of patients with diagnosed vascular disease and may be even more prevalent among women with ASCVD (10,11).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Gorter, 2004, Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm, Atherosclerosis source
Not checked in the free run.
- cites [11] Brevetti, 2006, Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity, J Vasc Surg source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe latest prevalence estimates of MetS in men and women are 35% and 33%, respectively.
“The latest prevalence estimates of MetS in men and women are 35% and 33%, respectively (42).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Go, 2014, Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenExcess ectopic and/or visceral adiposity is fundamental to the pathophysiology of MetS.
“Excess ectopic and/or visceral adiposity is fundamental to the pathophysiology of MetS.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the Framingham Offspring Study, both MetS and T2D increased the risk of stroke by approximately 2-fold, and those patients with both had an even higher risk.
“In the Framingham Offspring Study, both MetS and T2D increased the risk of stroke by approximately 2-fold, and those patients with both had an even higher risk (12).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Najarian, 2006, Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring study, Arch Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationFilipina women may have higher waist circumference and truncal fat and 3- to 4-fold higher rates of type 2 diabetes (T2D) and MetS compared with Caucasian women, controlling for other factors.
“Similarly, Filipina women may have higher waist circumference and truncal fat and 3-to 4-fold higher rates of type 2 diabetes (T2D) and MetS compared with Caucasian women, controlling for other factors (17).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Araneta, 2002, Type 2 diabetes and metabolic syndrome in Filipina-American women, Diabetes Care source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningBecause forecasts suggest that over one-half of the U.S. population will be obese by the year 2030, rates of MetS will almost certainly increase over the next decade.
“Because forecasts suggest that over one-half of the U.S. population will be obese by the year 2030, rates of MetS will almost certainly increase over the next decade.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMetS is associated with serious and extensive comorbidity.
“is associated with serious and extensive comorbidity”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenObesity is a MetS risk factor that is imperfectly gauged by body mass index and/or waist circumference, and is modulated by adipocyte distribution, size, and function, as well as race, behavior, and lifestyle.
“AC.4.Obesity is a MetS risk factor that is imperfectly gauged by body mass index and/or waist circumference, and is modulated by adipocyte distribution, size, and function, as well as race, behavior, and lifestyle.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenMetS is a progressive pathophysiological state associated with substantially increased risk for development of type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD).
“AC.1.Metabolic syndrome (MetS) is a progressive pathophysiological state associated with substantially increased risk for development of type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMetS is clinically manifested by a cluster of risk factors that are causally inter-related, not aggregating by chance alone.
“AC.2.MetS is clinically manifested by a cluster of risk factors that are causally inter-related (not aggregating by chance alone).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe current definition of MetS identifies a population at increased ASCVD risk.
“First, the current definition of MetS identifies a population at increased ASCVD risk”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMetS is progressive in its course.
“is progressive in its course”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSouth Asians have higher body fat content, waist to hip ratio, visceral fat to subcutaneous fat ratio, and adipocyte area than Caucasians matched for age, sex, and body mass index (BMI).
“For example, South Asians have higher body fat content, waist to hip ratio, visceral fat to subcutaneous fat ratio, and adipocyte area than Caucasians matched for age, sex, and body mass index (BMI) (15,16).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [15] Anand, 2011, Adipocyte hypertrophy, fatty liver, and metabolic risk factors in South Asians: The Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE), PLOS One source
Not checked in the free run.
- cites [16] Chandalia, 2007, Insulin resistance and body fat distribution in South Asian men compared to Caucasian men, PLOS One source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenThe TT identified disparity in care of patients with MetS to be a critical area for improvement.
“The TT identified disparity in care of patients with MetS to be a critical area for improvement.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe Healthy Living Partnerships to Prevent Diabetes Study, a DPP-like lifestyle weight-loss program over 2 years using community health workers, found that among 301 randomized patients, the intervention group achieved significant reductions in weight, BMI, waist circumference, glucose, insulin, and HOMA-IR compared with control subjects, with 46.5% achieving ≥5% weight loss and 21.3% achieving ≥
“The Healthy Living Partnerships to Prevent Diabetes Study implemented a DPP-like lifestyle weight-loss program over 2 years by using a local diabetes education program with community health workers, involving weekly visits over the first 6 months and twice monthly visits over the next 18 months (83).Among 301 randomized patients, the intervention group achieved significant reductions in weight, B”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Katula, 2013, The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial, Am J Prev Med source
Not checked in the free run.
May combine two claims.
PremisecitationMedicare beneficiaries in the same market as a commercial ACO realized decreases in total health care spending over 2 years, primarily due to reduced outpatient office visits, minor procedures, imaging, and laboratories.
“Medicare beneficiaries in the same market as a commercial ACO realized decreases in total health care spending over 2 years, primarily due to reduced outpatient office visits, minor procedures, imaging, and laboratories.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] McWilliams, 2013, Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationLarger provider groups attenuated racial disparities in some areas, but did not change disparities on other metrics, such as hospitalization rates.
“Although larger provider groups attenuated racial disparities in some areas, they did not change disparities on other metrics, such as hospitalization rates (107).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [107] Anderson, 2014, Quality of care and racial disparities in Medicare among potential ACOs, J Gen Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationAn extension study of DEPLOY found that both control and intervention arms maintained weight changes compared with baseline, and those in the initial intervention group lost a further 1.5% of body weight, with significant decreases in total cholesterol and systolic blood pressure.
“An extension study in which both the control and intervention arms were offered an 8-month lifestyle maintenance program found that both groups maintained weight changes compared with baseline, and those in the initial intervention group lost a further 1.5% of body weight, with significant decreases in total cholesterol and systolic blood pressure (79).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Ackermann, 2011, Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study, Chronic Illn source
Not checked in the free run.
May combine two claims.
PremisecitationA randomized controlled trial in 2 community health centers enrolled 525 patients with uncontrolled ASCVD, T2D, hypertension, or hyperlipidemia; results showed that pairing nurse practitioners and community health workers demonstrated significant reductions in blood pressure, cholesterol, and HbA1c over 1 year of follow-up compared with usual care.
“A randomized controlled trial in 2 community health centers enrolled 525 patients with uncontrolled ASCVD, T2D, hypertension, or hyperlipidemia; results showed that pairing nurse practitioners and community health workers demonstrated significant reductions in blood pressure, cholesterol, and HbA 1c over 1 year of follow-up compared with usual care (86).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Allen, 2011, Community Outreach and Cardiovascular Health (COACH) trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers, Circ Cardiovasc Qual Outcomes source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S2 (checkable). May combine two claims.
Interpretationnone givenWell-intentioned alteration of existing diagnostic criteria around racial differences could stigmatize minority populations and lead to undesirable consequences.
“In addition to this and other race-specific issues, however, TT participants recognized that wellintentioned alteration of existing diagnostic criteria around racial differences could stigmatize minority populations and lead to undesirable consequences.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe TT acknowledges that the concepts of staging and subtyping are works in progress and require further modification, testing, and validation before they can be used routinely in clinical care.
“The TT acknowledges that the concepts of staging and subtyping are works in progress and require further modification, testing, and validation before they can be used routinely in clinical care.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe Look AHEAD trial provides the longest-term evidence of the effect of an intensive lifestyle intervention in overweight and obese adults with T2D; at 8 years, 50.3% in the intervention group versus 35.7% in the usual care group lost ≥5% of body weight, and 26.9% versus 17.2% lost ≥10% of body weight.
“The Look AHEAD (Action for Health in Diabetes) trial provides the longest-term evidence of the effect of an intensive lifestyle intervention in overweight and obese adults with T2D.The curriculum was modified from the DPP and included structured meal plans and moderate exercise up to 200 min/week.At 8 years, 50.3% in the intervention group versus 35.7% in the usual care group lost $5% of body”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] 2014, Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD Study, Obesity (Silver Spring) source
Not checked in the free run.
May combine two claims.
PremisecitationSeveral dietary patterns, such as the DASH and Mediterranean diets, may reduce blood pressure, improve lipids, reduce inflammation, and reduce risk for ASCVD.
“Several dietary patterns, such as the DASH (Dietary Approaches to Stop Hypertension) and Mediterranean diets, may reduce blood pressure, improve lipids, reduce inflammation, and reduce risk for ASCVD (28,70).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [28] Eckel, 2014, 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol source
Not checked in the free run.
- cites [70] Estruch, 2013, Primary prevention of cardiovascular disease with a Mediterranean diet, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationOn average, African-Americans have higher HDL-C and lower triglyceride levels.
“On average, African-Americans have higher HDL-C and lower triglyceride levels(72).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Frank, 2014, Racial/ethnic differences in dyslipidemia patterns, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationThe Group Health Cooperative reduced physician panel sizes, increased ancillary staff, lengthened visit times, and provided time for team care planning, in addition to expanding technology to better engage patients; comparison with control clinics demonstrated better patient satisfaction scores, reduced provider burnout, improved performance on quality of care metrics, and reduced emergency
“The Group Health Cooperative reduced physician panel sizes, increased ancillary staff, lengthened visit times, and provided time for team care planning, in addition to expanding technology to better engage patients.Comparison with control clinics in the area demonstrated better patient satisfaction scores, reduced provider burnout, improved performance on quality of care metrics, and reduced”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Reid, 2010, The Group Health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers, Health Aff (Millwood) source
Not checked in the free run.
May combine two claims.
PremisecitationThe Geisinger ProvenHealth Navigator demonstrated a reduction in the incidence of end-stage renal disease and amputation among patients with T2D over 4 years, although without a change in myocardial infarction or stroke.
“For example, the Geisinger ProvenHealth Navigator demonstrated a reduction in the incidence of end-stage renal disease and amputation among patients with T2D over 4 years, although without a change in myocardial infarction or stroke (98).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [98] Maeng, 2012, Can a patient-centered medical home lead to better patient outcomes? The quality implications of Geisinger's ProvenHealth Navigator, Am J Med Qual source
Not checked in the free run.
May combine two claims.
PremisecitationHigher levels of physical activity are associated with lower rates of chronic diseases and increased longevity.
“Many observational studies show an association between higher levels of physical activity and lower rates of chronic diseases and increased longevity (67).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Warburton, 2010, A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults, Int J Behav Nutr Phys Act source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Interpretationnone givenCurrent definitions of abdominal obesity are imprecise and not well suited for many populations.
“Second, participants felt that better metrics are needed to define abdominal obesity, as current definitions are imprecise and not well suited for many populations.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe presence of ectopic fat and/or visceral adipose tissue is critical to the pathogenesis of MetS and may explain some of the variability in phenotypic presentation across racial groups.
“KF.2.The presence of ectopic fat and/or visceral adipose tissue is critical to the pathogenesis of MetS and may explain some of the variability in phenotypic presentation across racial groups.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationEvaluation of a PCMH model in West Virginia found that an EHR-based screening tool identified 11% of over 94,000 patients as being at risk for T2D, enabling the facility to better screen and connect patients to local lifestyle intervention programs.
“Evaluation of another such model in West Virginia found that an EHR-based screening tool identified 11% of over 94,000 patients as being at risk for T2D (99), enabling the facility to better screen and connect patients to local lifestyle intervention programs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] Baus, 2013, Registry-based diabetes risk detection schema for the systematic identification of patients at risk for diabetes in West Virginia primary care centers, Perspect Health Inf Manag
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe paradox of higher HDL-C and lower triglycerides in African-Americans may translate to underdiagnosis of MetS in African-Americans using current diagnostic criteria, which would likely result in lack of treatment of MetS in this population.
“This paradox may translate to underdiagnosis of MetS in African-Americans using current diagnostic criteria, which would likely result in lack of treatment of MetS in this population.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA program targeting a predominantly low-income non-Caucasian urban population delivered a lifestyle intervention in 12 weeks using group sessions and found significant reductions in the proportion of subjects meeting the MetS waist circumference (90% to 68%; p=0.009) and hypertension (68% to 48%; p=0.04) criteria over 6 months; at 3 months, 46.4% lost ≥5% of body weight and 26% lost ≥7% of body
“A program targeting a predominantly low-income non-Caucasian urban population delivered a lifestyle intervention in 12 weeks using group sessions and found significant reductions in the proportion of subjects meeting the MetS waist circumference (90% to 68%; p ¼ 0.009) and hypertension (68% to 48%; p ¼ 0.04) criteria over 6 months.At 3 months, 46.4% lost $5% of body weight and 26% lost $7% of body”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Seidel, 2008, Translating the Diabetes Prevention Program into an urban medically underserved community: a non-randomized prospective intervention study, Diabetes Care source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of 36 family practices implementing PCMH components over 26 months, improvement was seen in prevention and chronic care quality metrics, but not in patient-assessed outcomes.
“In another study of 36 family practices implementing PCMH components over 26 months, improvement was seen in prevention and chronic care quality metrics, but not in patient-assessed outcomes (96).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] Jaén, 2010, Patient outcomes at 26 months in the patient-centered medical home National Demonstration Project, Ann Fam Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningMetS is a cluster of risk factors, both formally defined and less well recognized, that increase the risk of certain diseases.
“KF.1.MetS is a cluster of risk factors, both formally defined and less well recognized, that increase the risk of certain diseases.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
PremisecitationThe DEPLOY study, a pilot cluster-randomized trial comparing group-based DPP lifestyle intervention through a YMCA with brief counseling, found that among 92 randomized participants, at both 4 to 6 and 12 to 14 months, the percent change in weight and BMI, as well as the change in total cholesterol, was significantly greater in the intervention group.
“The DEPLOY (Diabetes Education & Prevention with a Lifestyle Intervention Offered at the YMCA) study was a pilot clusterrandomized trial comparing group-based DPP lifestyle intervention through a Young Men's Christian Association (16 group sessions with goals of 5% to 7% reduction in baseline body weight and 150 min/ week of moderate exercise) with brief counseling.Among 92 randomized participants”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Ackermann, 2008, Translating the Diabetes Prevention Program in the community. The Deploy Pilot Study, Am J Prev Med source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough different financial models have been proposed and are incorporated in some PCMH models, evaluations do not specifically address the effectiveness of these strategies, nor have most studies demonstrated overall short-term cost savings.
“Although different financial models have been proposed and are incorporated in some PCMH models, evaluations do not specifically address the effectiveness of these strategies, nor have most studies demonstrated overall short-term cost savings (100).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Edwards, 2014, Structuring payment to medical homes after the Affordable Care Act, J Gen Intern Med source
Not checked in the free run.
May combine two claims.
PremisecitationAfrican-American beneficiaries with T2D were less likely to receive LDL testing and retinal examinations and were more likely to be hospitalized than Caucasian beneficiaries.
“African-American beneficiaries with T2D were less likely to receive LDL testing and retinal examinations and were more likely to be hospitalized than Caucasian beneficiaries.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Anderson, 2014, Quality of care and racial disparities in Medicare among potential ACOs, J Gen Intern Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn 2005, the NCEP-ATP III criteria were modified to suggest lower waist circumference cutpoints for Asian Americans (≥90 cm in men and ≥80 cm in women).
“In 2005, the NCEP-ATP III criteria were modified to suggest lower waist circumference cutpoints for Asian Americans ($90 cm [35 inches] in men and $80 cm [31 inches] in women) (2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn NHANES 2003-2006, MetS prevalence was 6.8% in normal-weight men, 29.8% in overweight men, and 65% in obese men, and 9.3%, 33.1%, and 56.1% in women, respectively.
“In men in the NHANES (National Health and Nutrition Examination Survey) from 2003 to 2006, MetS was present in 6.8% of normal weight, 29.8 % of overweight, and 65% of obese individuals (14).Similarly, among women, 9.3% of normal weight, 33.1% of overweight, and 56.1% of obese individuals had MetS (14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Ervin, 2009, Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006, Natl Stat Health Report
Not checked in the free run.
May combine two claims.
PremisecitationPeer leaders can effectively provide education and support for lifestyle, as demonstrated in a study where 116 Latino adults with T2D were randomized to receive diabetes self-management education and either 12 months of weekly group sessions with peer leaders or 12 months of telephone outreach with health workers; both groups achieved significant HbA1c, blood pressure, and waist circumference
“Finally, peer leaders can effectively provide education and support for lifestyle.This was demonstrated in a study where 116 Latino adults with T2D were randomized to receive diabetes self-management education and either 12 months of weekly group sessions with peer leaders or 12 months of telephone outreach with health workers (87).Both groups achieved significant HbA 1c , blood pressure, and”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Tang, 2014, Comparative effectiveness of peer leaders and community health workers in diabetes self-management support: results of a randomized controlled trial, Diabetes Care source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationIn Colorado Heart Healthy Solutions, community health workers conducted screenings, assessed readiness for change, and provided education and medical referrals to patients with an uncontrolled risk factor for coronary heart disease or a Framingham Risk Score ≥10%; they found significant reductions in Framingham Risk score, blood pressure, and cholesterol at retesting, and in multivariable models,
“In Colorado Heart Healthy Solutions, community health workers conducted screenings, assessed readiness for change, and provided education and medical referrals to patients with an uncontrolled risk factor for coronary heart disease or a Framingham Risk Score $10%.They provided further phone follow-up, and found significant reductions in Framingham Risk score, blood pressure, and cholesterol at ret”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Krantz, 2013, Effectiveness of a community health worker cardiovascular risk reduction program in public health and health care settings, Am J Public Health source
Not checked in the free run.
May combine two claims.
PremisecitationA systematic review of 31 studies found a positive effect of components of the PCMH model on patient and staff experiences, as well as positive effects on preventive services, with reduction in emergency department visits in older adults, but no effect on hospital admissions or total costs.
“A systematic review of 31 studies found a positive effect of components of the PCMH model on patient and staff experiences, as well as positive effects on preventive services, with reduction in emergency department visits in older adults, but no effect on hospital admissions or total costs (95).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Jackson, 2013, Improving patient care. The patient centered medical home. A systematic review, Ann Intern Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRecently, the AACE and the American College of Endocrinology developed an advanced framework for defining obesity as a chronic disease characterized by pathophysiological processes that result in increased adipose tissue mass and can result in increased morbidity and mortality, with MetS as one such important consequence.
“Recently, the AACE and the American College of Endocrinology developed an advanced framework for defining obesity as a chronic disease characterized by pathophysiological processes that result in increased adipose tissue mass and can result in increased morbidity and mortality (40), with MetS as 1 such important consequence.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Garvey, 2014, American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease, Endocr Pract source
Not checked in the free run.
May combine two claims.
PremisecitationMetS consists of elements that do not aggregate by chance alone and are causally inter-related, and each element contributes independently to an increased risk for ASCVD.
“MetS consists of elements that do not aggregate by chance alone and are causally inter-related, and each element contributes independently to an increased risk for ASCVD (3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Yudkin, 2004, Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH Study, Metabolism source
Not checked in the free run.
May combine two claims.
PremisecitationA cultural adaptation of the DPP in African-American churches involving 37 participants compared an abbreviated 6-week program to a longer 16-week program and found that fasting glucose and BMI decreased significantly in both groups at 12 months.
“Another cultural adaptation of the DPP in African-American churches involved 37 participants and compared an abbreviated 6-week program to a longer 16-week program; it found that fasting glucose and BMI decreased significantly in both groups at 12 months (90).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [90] Boltri, 2011, Translation of the National Institutes of Health Diabetes Prevention Program in African American churches, J Natl Med Assoc
Not checked in the free run.
May combine two claims.
PremisecitationThe Lawrence Latino Diabetes Prevention project, which recruited 312 participants at high risk for T2D for a lifestyle intervention involving 3 individual and 13 group sessions over 12 months versus usual care, found a significant reduction in weight, BMI, and HbA1c in the intervention group as compared with usual care at 1 year.
“To emphasize the importance of addressing disparities, the TT discussed key studies such as the Lawrence Latino Diabetes Prevention project (89), which recruited 312 participants at high risk for T2D for a lifestyle intervention involving 3 individual and 13 group sessions over 12 months versus usual care.The curriculum was adapted to address knowledge gaps and language barriers, customize dietary”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Ockene, 2012, Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project, Am J Public Health source
Not checked in the free run.
May combine two claims.
PremisecitationThere were some improvements in LDL testing for patients with T2D and ASCVD but not on other quality metrics in the commercial ACO evaluation.
“There were some improvements in LDL testing for patients with T2D and ASCVD but not on other quality metrics (103).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] McWilliams, 2013, Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract, JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationAn evaluation of Medicare enrollees in the Medicare Physician Group Practice Demonstration compared with control subjects found that the savings were highest for acute care and dually-eligible beneficiaries, with an overall reduction in 30-day medical readmissions.
“An evaluation of Medicare enrollees in the Medicare Physician Group Practice Demonstration compared with control subjects found that the savings were highest for acute care and dually-eligible beneficiaries, with an overall reduction in 30-day medical readmissions (104).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [104] Colla, 2012, Spending differences associated with the Medicare Physician Group Practice Demonstration, JAMA source
Not checked in the free run.
The paper relies on this without support.
There is no targeted comprehensive care approach to address the needs of MetS patients.
“Second, there is no targeted comprehensive care approach to address the needs of MetS patients.”
The paper relies on this without support.
There is no system to implement risk reduction and disease prevention for MetS.
“Third, assuming there was such an approach, there is no system to implement risk reduction and disease prevention.”
The paper relies on this without support.
The term MetS is the term most often used in scientific published data and by health care professionals.
“TT participants concluded that MetS was the term most often used in the scientific published data and by health care professionals.”
The paper relies on this without support.
Susceptibility to MetS transcends obesity, as there are obese individuals without MetS and nonobese individuals with MetS.
“Susceptibility to MetS transcends obesity, however, as there are obese individuals without MetS and nonobese individuals with MetS.”
The paper relies on this without support.
Several factors modulate the prevalence of MetS in the presence of obesity, including lifestyle factors such as poor nutritional quality and lack of physical activity.
“Several factors modulate the prevalence of MetS in the presence of obesity, including lifestyle factors such as poor nutritional quality and lack of physical activity.”
The paper relies on this without support.
Although risk for adverse outcomes generally increases with each subsequent stage of MetS, the absolute risk for developing MetS consequences varies substantially within populations.
“It should be noted that although risk for adverse outcomes generally increases with each subsequent stage, the absolute risk for developing MetS consequences varies substantially within populations.”
The paper relies on this without support.
Integrated health networks allow patients to monitor their own progress, which improves self-motivation and patient engagement in self-care.
“Integrated health networks allow patients to monitor their own progress, which improves selfmotivation and patient engagement in self-care.”
The paper relies on this without support.
The NCEP-ATP III criteria do not fully encompass the pathophysiological complexity of the syndrome, recognize predisposition to different types of end-organ damage, or account for health disparities according to race, sex, or socioeconomic status, in screening for or treating the syndrome.
“However, these criteria do not fully encompass the pathophysiological complexity of the syndrome, recognize predisposition to different types of end-organ damage, or account for health disparities according to race, sex, or socioeconomic status, in screening for or treating the syndrome.”
The paper relies on this without support.
MetS is typically under-recognized in the clinical setting, even just on the basis of the 5 standard criteria.
“MetS is typically under-recognized in the clinical setting, even just on the basis of the 5 standard criteria.”
The paper relies on this without support.
Additional elements of MetS include high apolipoprotein B, small low-density lipoprotein (LDL) particle size, endothelial dysfunction, insulin resistance, and prothrombotic and proinflammatory states.
“Additional elements of MetS include high apolipoprotein B, small low-density lipoprotein (LDL) particle size, endothelial dysfunction, insulin resistance, and prothrombotic and proinflammatory states.”
The paper relies on this without support.
These additional elements are less widely appreciated as components of MetS and are not typically measured in a clinical setting.
“Not only are these less widely appreciated as components of MetS, but they are also not typically measured in a clinical setting.”
The paper relies on this without support.
There is significant heterogeneity of expert opinion as to what constitutes MetS, to what degree it represents a syndrome or a disease, and whether it has any health-related effects.
“There is significant heterogeneity of expert opinion as to what constitutes MetS, to what degree it represents a syndrome or a disease, and whether it has any health-related effects”
The paper relies on this without support.
Disparity can manifest as decreased accessibility to health care and failure to recognize or appropriately treat at-risk populations.
“Disparity can manifest as decreased accessibility to health care and failure to recognize or appropriately treat at-risk populations.”
The paper relies on this without support.
Other nonracial, high-risk, under-represented populations likely requiring more intensive consideration include patients with human immunodeficiency virus/acquired immunodeficiency syndrome, cancer survivors, individuals with severe mental illness, and children with developmental disabilities.
“Other nonracial, high-risk, under-represented populations likely requiring more intensive consideration include patients with human immunodeficiency virus/acquired immunodeficiency syndrome, cancer survivors, individuals with severe mental illness, and children with developmental disabilities.”
The paper relies on this without support.
Many provisions of the Affordable Care Act (ACA) would support this implementation.
“It is important to note that many of the provisions of the Affordable Care Act (ACA) would support this implementation.”
The paper relies on this without support.
The PCMH addresses each of the aforementioned principles of care model implementation.
“To varying degrees, the PCMH addresses each of the aforementioned principles of care model implementation.”
The paper relies on this without support.
Comparisons across studies on the PCMH are often difficult because of differences in definition and focus.
“However, comparisons across studies on the PCMH are often difficult because of differences in definition and focus.”
The paper relies on this without support.
Long-term data on PCMH models is limited, as most of these models were implemented over the last 5 to 10 years.
“Long-term data is also limited, as most of these models were implemented over the last 5 to 10 years.”
The paper relies on this without support.
The PCMH model affects MetS sequelae and outcomes.
“The PCMH model affects MetS sequelae and outcomes.”
The paper relies on this without support.
There is less published data available to assess PCMH reimbursement strategies to facilitate coordinated care or on how this model addresses health care disparities.
“There is less published data available to assess PCMH reimbursement strategies to facilitate coordinated care or on how this model addresses health care disparities.”
The paper relies on this without support.
The ACO is a larger organization than the PCMH that includes hospitals and specialty care.
“Although the PCMH focuses on coordination at the level of primary care, the ACO is a larger organization that includes hospitals and specialty care.”
The paper relies on this without support.
Compared with many PCMH models, the ACO's reimbursement changes and cost-saving goals are more explicit and are better aligned to facilitate coordinated care.
“Compared with many PCMH models, the ACO's reimbursement changes and cost-saving goals are more explicit and are better aligned to facilitate coordinated care.”
The paper relies on this without support.
ACO design has not specifically addressed health care disparities.
“Although integration of care into larger organizations may address health care disparities, this has not been specifically addressed in ACO design.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is an increasing appreciation of the common pathophysiology and interrelationship of cardiometabolic risk factors leading to both adverse cardiovascular and adverse kidney outcomes in people with diabetes, including ASCVD, heart failure, and CKD.
“There is an increasing appreciation of the common pathophysiology and interrelationship of cardiometabolic risk factors leading to both adverse cardiovascular and adverse kidney outcomes in people with diabetes, including ASCVD, heart failure, and chronic kidney disease (CKD) (16).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [16]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredMetabolic syndrome is closely associated with diet.
“Existing research indicates that metabolic syndrome is closely associated with diet [6].”
From Impact of Dietary Patterns on Metabolic Syndrome in Young Adults: A Cross-Sectional Study (2024) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Sector count does not match the list
MinorThe text says the plan covers 8 sectors, but the subsequent semicolon-separated list names 11. Combining some entries could produce eight groups, but the list does not present them that way.
“The plan has 5 primary strategies and proposes evidence-based interventions within 8 economic sectors.”
“Involved sectors include: business and industry; education; health care; mass media; parks, recreation, fitness, and sports; public health; transportation; land use; community design; volunteer; and nonprofit.”
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257 · see citing works
RetractedAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works
Self-citationDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works
Self-citationRole of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works
Self-citationThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982 · see citing works
Self-citationHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · see citing works
Self-citationHeart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,207 · see citing works
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945 · see citing works
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · see citing works
Self-citation2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058 · see citing works
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845 · see citing works
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009 · see citing works
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · eScholarship (California Digital Library) · Cited by 2,601 · see citing works
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,377 · see citing works
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,363 · see citing works
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261 · see citing works
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · see citing works
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888 · see citing works
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · see citing works
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159228 · Cited by 1,589 · see citing works
Self-citationBody Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481 · cited 1× · see citing works
“The several ectopic fat depots associated with increased cardiometabolic risk include excess liver, pericardial and epicardial, retroperitoneal, and intramuscular fat (45).”
BackgroundSelf-citationAlexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · see citing works
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160 · see citing works
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066 · see citing works
Ervin, R. B. (2009) · PubMed · Cited by 1,003 · see citing works
Lifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945 · see citing works
A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults
Warburton, D. E., Charlesworth, S., Ivey, A., Nettlefold, L., & Bredin, S. S. (2010) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-7-39 · Cited by 902 · see citing works
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842 · see citing works
The Patient-Centered Medical Home: A Systematic Review
Jackson, G. L., Powers, B. J., Chatterjee, R., Prvu Bettger, J., Kemper, A. R., Hasselblad, V., Dolor, R. J., Irvine, R. J., Heidenfelder, B. L., Kendrick, A. S., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00579 · Cited by 699 · see citing works
Body Fat Distribution, Incident Cardiovascular Disease, Cancer, and All-Cause Mortality
Britton, K. A., Massaro, J. M., Murabito, J. M., Kreger, B. E., Hoffmann, U., & Fox, C. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.027 · Cited by 687 · see citing works
Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
Neeland, I. J., Turer, A. T., Ayers, C. R., Powell‐Wiley, T. M., Vega, G. L., Farzaneh‐Far, R., Grundy, S. M., Khera, A., McGuire, D. K., & de Lemos, J. A. (2012) · JAMA · doi:10.1001/2012.jama.11132 · Cited by 650 · see citing works
Self-citationAnderson, L. M., Quinn, T. A., Glanz, K., Ramirez, G., Kahwati, L. C., Johnson, D. B., Buchanan, L. R., Archer, W. R., Chattopadhyay, S., Kalra, G. P., et al. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.07.003 · Cited by 623 · see citing works
Translating the Diabetes Prevention Program into the Community
Ackermann, R. T., Finch, E. A., Brizendine, E., Zhou, H., & Marrero, D. G. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.06.035 · Cited by 622 · see citing works
Components of a Cardioprotective Diet: New Insights
Mozaffarian, D., Appel, L. J., & Van Horn, L. (2011) · Circulation · doi:10.1161/circulationaha.110.968735 · Cited by 571 · see citing works
Reid, R. J., Coleman, K., Johnson, E. A., Fishman, P. A., Hsu, C., Soman, M. P., Trescott, C. E., Erikson, M., & Larson, E. B. (2010) · Health Affairs · doi:10.1377/hlthaff.2010.0158 · Cited by 567 · see citing works
Weintraub, W. S., Daniels, S. R., Burke, L. E., Franklin, B. A., Goff, D. C., Hayman, L. L., Lloyd-Jones, D., Pandey, D. K., Sanchez, E. J., Schram, A. P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182285a81 · Cited by 541 · see citing works
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500 · cited 1× · see citing works
“First, the correlation among BMI, waist circumference, and VAT is highly variable among different racial groups, prompting the American Diabetes Association and the International Diabetes Federation to define different cutoffs for abnormal BMI and waist circumference, respectively, in Asian populations (49,50).”
BackgroundSelf-citationNeeland, I. J., Ayers, C. R., Rohatgi, A. K., Turer, A. T., Berry, J. D., Das, S. R., Vega, G. L., Khera, A., McGuire, D. K., Grundy, S. M., et al. (2013) · Obesity · doi:10.1002/oby.20135 · Cited by 497 · see citing works
Self-citationMcLaughlin, T., Lamendola, C., Liu, A., & Abbasi, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0615 · Cited by 468 · see citing works
A Pooled Analysis of Waist Circumference and Mortality in 650,000 Adults
Cerhan, J. R., Moore, S. C., Jacobs, E. J., Kitahara, C. M., Rosenberg, P. S., Adami, H.-O., Ebbert, J. O., English, D. R., Gapstur, S. M., Giles, G. G., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.11.011 · Cited by 443 · see citing works
Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults
Chen, J., Muntner, P., Hamm, L. L., Fonseca, V. A., Batuman, V., Whelton, P. K., & He, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000046029.53933.09 · Cited by 396 · see citing works
Vgontzas, A. N., Legro, R. S., Bixler, E. O., Grayev, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7185 · Cited by 371 · see citing works
McLaughlin, T., Sherman, A., Tsao, P., Gonzalez, O., Yee, G., Lamendola, C., Reaven, G. M., & Cushman, S. W. (2007) · Diabetologia · doi:10.1007/s00125-007-0708-y · Cited by 364 · see citing works
Racial/ethnic differences in dyslipidemia patterns
Frank, A. T. H., Zhao, B., Jose, P. O., Azar, K. M. J., Fortmann, S. P., & Palaniappan, L. P. (2014) · Circulation · doi:10.1161/circulationaha.113.005757 · Cited by 327 · see citing works
Influence of body fat content and distribution on variation in metabolic risk
Vega, G. L., Adams-Huet, B., Peshock, R., Willett, D., Shah, B., & Grundy, S. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0814 · Cited by 312 · see citing works
Self-citationThe Relationship of Body Mass and Fat Distribution With Incident Hypertension
Chandra, A., Neeland, I. J., Berry, J. D., Ayers, C. R., Rohatgi, A., Das, S. R., Khera, A., McGuire, D. K., de Lemos, J. A., & Turer, A. T. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.057 · Cited by 264 · see citing works
Self-citationFesta, A., Agostino, R. B. D., Mykkänen, L., Tracy, R. P., Zaccaro, D. J., Hales, C. N., & Haffner, S. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.562 · Cited by 262 · see citing works
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1796 · Cited by 257 · see citing works
Insulin resistance and body fat distribution in South Asian men compared to Caucasian men
Chandalia, M., Lin, P., Seenivasan, T., Livingston, E. H., Snell, P. G., Grundy, S. M., & Abate, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000812 · Cited by 253 · see citing works
Self-citationGarvey, W. T., Garber, A. J., Mechanick, J. I., Bray, G. A., Dagogo-Jack, S., Einhorn, D., Grunberger, G., Handelsman, Y., Hennekens, C. H., Hurley, D. L., et al. (2014) · Endocrine Practice · doi:10.4158/ep14280.ps · Cited by 238 · see citing works
Self-citationInsulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Gm, R. (2005) · PubMed · Cited by 238 · see citing works
Factor Analysis of Metabolic Syndrome Using Directly Measured Insulin Sensitivity
Hanley, A. J. G., Karter, A. J., Festa, A., D’Agostino, R., Wagenknecht, L. E., Savage, P., Tracy, R. P., Saad, M. F., & Haffner, S. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2642 · Cited by 229 · see citing works
Araneta, M., & Barrett-Connor, E. (2005) · Obesity Research · doi:10.1038/oby.2005.176 · Cited by 221 · see citing works
Self-citationGorter, P. M., Olijhoek, J. K., van der Graaf, Y., Algra, A., Rabelink, T. J., & Visseren, F. L. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.033 · Cited by 216 · see citing works
Goodman, E., Dolan, L. M., Morrison, J. A., & Daniels, S. R. (2005) · Circulation · doi:10.1161/01.cir.0000161957.34198.2b · Cited by 213 · see citing works
Ockene, I. S., Tellez, T. L., Rosal, M. C., Reed, G. W., Mordes, J., Merriam, P. A., Olendzki, B. C., Handelman, G., Nicolosi, R., & Ma, Y. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300357 · Cited by 201 · see citing works
Solymoss, B., Bourassa, M. G., CAMPEAU, L. A., Sniderman, A. D., Marcil, M., Lespérance, J., Lévesque, S., & Varga, S. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.032 · Cited by 194 · see citing works
Patient outcomes at 26 months in the patient-centered medical home National Demonstration Project
Jaen, C. R., Ferrer, R. L., Miller, W. L., Palmer, R. F., Wood, R., Davila, M., Stewart, E. E., Crabtree, B. F., Nutting, P. A., & Stange, K. C. (2010) · The Annals of Family Medicine · doi:10.1370/afm.1121 · Cited by 194 · see citing works
Relation of Regional Fat Distribution to Left Ventricular Structure and Function
Neeland, I. J., Gupta, S. K., Ayers, C. R., Turer, A. T., Rame, J. E., Das, S. R., Berry, J. D., Khera, A., McGuire, D. K., Vega, G. L., et al. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000532 · Cited by 192 · see citing works
Self-citationTang, T. S., Funnell, M., Sinco, B., Piatt, G., Palmisano, G., Spencer, M. S., Kieffer, E. C., & Heisler, M. (2014) · Diabetes Care · doi:10.2337/dc13-2161 · Cited by 188 · cited 2× · see citing works
“This was demonstrated in a study where 116 Latino adults with T2D were randomized to receive diabetes self-management education and either 12 months of weekly group sessions with peer leaders or 12 months of telephone outreach with health workers (87).”
BackgroundAllen, J. K., Dennison-Himmelfarb, C. R., Szanton, S. L., Bone, L., Hill, M. N., Levine, D. M., West, M., Barlow, A., Lewis-Boyer, L., Donnelly-Strozzo, M., et al. (2011) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.961573 · Cited by 187 · see citing works
Anand, S. S., Tarnopolsky, M. A., Rashid, S., Schulze, K. M., Desai, D., Mente, A., Rao, S., Yusuf, S., Gerstein, H. C., & Sharma, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022112 · Cited by 174 · see citing works
The Association of Differing Measures of Overweight and Obesity With Prevalent Atherosclerosis
See, R., Abdullah, S. M., McGuire, D. K., Khera, A., Patel, M. J., Lindsey, J. B., Grundy, S. M., & de Lemos, J. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.066 · Cited by 164 · see citing works
Self-citationTranslating the Diabetes Prevention Program Into an Urban Medically Underserved Community
Seidel, M. C., Powell, R. O., Zgibor, J. C., Siminerio, L. M., & Piatt, G. A. (2008) · Diabetes Care · doi:10.2337/dc07-1869 · Cited by 164 · see citing works
Spending differences associated with the Medicare Physician Group Practice Demonstration
Colla, C. H., Wennberg, D. E., Meara, E., Skinner, J. S., Gottlieb, D., Lewis, V. A., Snyder, C. M., & Fisher, E. S. (2012) · JAMA · doi:10.1001/2012.jama.10812 · Cited by 163 · see citing works
Yudkin, J. S., Juhan-Vague, I., Hawe, E., Humphries, S. E., di Minno, G., Margaglione, M., Tremoli, E., Kooistra, T., Morange, P. E., Lundman, P., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.004 · Cited by 153 · see citing works
Type 2 diabetes and metabolic syndrome in Filipina-American women
Araneta, M. R. G., Wingard, D. L., & Barrett-Connor, E. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.494 · Cited by 149 · see citing works
Self-citationGallagher, E. J., & LeRoith, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2001 · Cited by 145 · see citing works
McWilliams, J. M., Landon, B. E., & Chernew, M. E. (2013) · JAMA · doi:10.1001/jama.2013.276302 · Cited by 142 · see citing works
Lipodystrophies: rare disorders causing metabolic syndrome
Garg, A., & Misra, A. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.003 · Cited by 138 · see citing works
The Healthy Living Partnerships to Prevent Diabetes Study
Katula, J. A., Vitolins, M. Z., Morgan, T. M., Lawlor, M. S., Blackwell, C. S., Isom, S. P., Pedley, C. F., & Goff, D. C. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.015 · Cited by 127 · see citing works
The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement
Handelsman, Y., Oral, E. A., Bloomgarden, Z. T., Brown, R. J., Chan, J. L., EINHORN, D. F., Garber, A. J., Garg, A., Garvey, W. T., Grunberger, G., et al. (2013) · Endocrine Practice · doi:10.4158/endp.19.1.v767575m65p5mr06 · Cited by 124 · see citing works
Self-citationInflammation in subcutaneous adipose tissue: relationship to adipose cell size
McLaughlin, T., Deng, A., Yee, G., Lamendola, C., Reaven, G., Tsao, P. S., Cushman, S. W., & Sherman, A. (2010) · Diabetologia · doi:10.1007/s00125-009-1496-3 · Cited by 105 · see citing works
Davis, D., Eccles, M., Grol, R. P. T. M., & Wensing, M. (2013) · Cited by 102 · see citing works
Krantz, M. J., Coronel, S. M., Whitley, E. M., Dale, R., Yost, J., & Estacio, R. O. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301068 · Cited by 99 · see citing works
Diabetes and Cancer—An AACE/ACE Consensus Statement
Handelsman, Y., LeRoith, D., Bloomgarden, Z. T., Dagogo-Jack, S. E., EINHORN, D. F., Garber, A. J., Grunberger, G., Harrell, R. M., Gagel, R. F., Lebovitz, H. E., et al. (2013) · Endocrine Practice · doi:10.4158/ep13248.cs · Cited by 99 · see citing works
Self-citationMasuo, K., Rakugi, H., Ogihara, T., Esler, M., & Lambert, G. W. (2010) · Current Diabetes Reviews · doi:10.2174/157339910790909396 · Cited by 91 · see citing works
Boltri, J. M., Davis‐Smith, M., Okosun, I. S., Seale, J. P., & Foster, B. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30301-1 · Cited by 88 · see citing works
Leptin and other components of the Metabolic Syndrome in Mauritius—a factor analysis
Hodge, A., Boyko, E., de Courten, M., Zimmet, P., Chitson, P., Tuomilehto, J., & Alberti, K. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801522 · Cited by 80 · see citing works
Efstathiou, S. P., Skeva, I. I., Zorbala, E., Georgiou, E., & Mountokalakis, T. D. (2012) · Circulation · doi:10.1161/circulationaha.111.034546 · Cited by 79 · see citing works
Kanaya, A. M., Araneta, M. R. G., Pawlowsky, S. B., Barrett-Connor, E., Grady, D., Vittinghoff, E., Schembri, M., Chang, A., Carrion-Petersen, M. L., Coggins, T., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.12.001 · Cited by 71 · see citing works
Self-citationEilat-Adar, S., Méte, M., Fretts, A. M., Fabsitz, R. R., Handeland, V., Lee, E. T., Loria, C. M., Xu, J., Yeh, J., & Howard, B. V. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.12.005 · Cited by 70 · see citing works
Maeng, D. D., Graf, T. R., Davis, D. E., Tomcavage, J., & Bloom, F. J. (2012) · American Journal of Medical Quality · doi:10.1177/1062860611417421 · Cited by 64 · see citing works
Broekhuizen, L. N., Boekholdt, S. M., Arsenault, B. J., Despres, J., Stroes, E. S., Kastelein, J. J., Khaw, K., & Wareham, N. J. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389397 · Cited by 62 · see citing works
Self-citationAckermann, R. T., Finch, E. A., Caffrey, H. M., Lipscomb, E. R., Hays, L. M., & Saha, C. (2011) · Chronic Illness · doi:10.1177/1742395311407532 · Cited by 58 · see citing works
Brevetti, G., Schiano, V., Sirico, G., Giugliano, G., Laurenzano, E., & Chiariello, M. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.02.048 · Cited by 55 · see citing works
Structuring payment to medical homes after the Affordable Care Act
Edwards, S. T., Abrams, M. K., Baron, R. J., Berenson, R. A., Rich, E. C., Rosenthal, G. E., Rosenthal, M. B., & Landon, B. E. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2848-3 · Cited by 46 · see citing works
Quality of care and racial disparities in Medicare among potential ACOs
Anderson, R. E., Ayanian, J. Z., Zaslavsky, A. M., & McWilliams, J. M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2900-3 · Cited by 41 · see citing works
Girman, C. J., Dekker, J. M., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi229 · Cited by 41 · see citing works
Garvey, W. T., Garber, A. J., Mechanick, J. I., Bray, G. A., Dagogo-Jack, S. E., EINHORN, D. F., Grunberger, G., Handelsman, Y., Hennekens, C. H., Hurley, D. L., et al. (2014) · Endocrine Practice · doi:10.4158/ep14279.cs · Cited by 38 · see citing works
Self-citationThe metabolic syndrome in Chinese, Malays and Asian Indians
Ang, L. W., Ma, S., Cutter, J. L., Chew, S. K., Tan, C. E., & Tai, E. S. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.05.003 · Cited by 34 · see citing works
A Work in Progress, but a Useful Construct
Beaser, R. S., & Levy, P. T. (2007) · Circulation · doi:10.1161/circulationaha.106.673616 · Cited by 33 · see citing works
Araneta, M. R. G., & Tanori, D. (2015) · PubMed · Cited by 30 · see citing works
Self-citationBozack, A. K., Millstein, S., Garcel, J. M., Kelly, K., Ruberto, R. A., & Weiss, L. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.140006 · Cited by 27 · see citing works
Ang, L. W., Ma, S., Cutter, J. L., Chew, S. K., Tan, C. L., & Tai, E. Y. S. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(04)00137-8 · Cited by 23 · see citing works
Egan, B. M., Laken, M. A., Wagner, C. S., Mack, S. S., Seymour‐Edwards, K., Dodson, J. A., Zhao, Y., & Lackland, D. T. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00491.x · Cited by 20 · see citing works
Self-citationWilkinson, C., Champion, J. D., & Sabharwal, K. (2013) · Journal for Healthcare Quality · doi:10.1111/jhq.12024 · Cited by 20 · see citing works
Coberley, C. R., Puckrein, G. A., Dobbs, A. C., McGinnis, M. A., Coberley, S. S., & Shurney, D. W. (2007) · Disease Management · doi:10.1089/dis.2007.641 · Cited by 19 · see citing works
Self-citationRacial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home
Simonetti, J. A., Fine, M. J., Chen, Y.-F., Simak, D., & Hess, R. (2014) · Diabetes Care · doi:10.2337/dc13-1332 · Cited by 19 · see citing works
Baus, A., Wood, G., Pollard, C. R., Summerfield, B., & White, E. (2013) · Europe PMC (PubMed Central) · Cited by 12 · see citing works
Najarian, R. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.1.106
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7
Flagged first, then by citations
3 of the 109 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Wilkinson, M. J., Manoogian, E. N. C., Zadourian, A., Lo, H., Fakhouri, S., Shoghi, A., Wang, X., Fleischer, J. G., Navlakha, S., Panda, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.004 · Cited by 927 · see citing works
Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881 · see citing works
Self-citationCircadian clocks and insulin resistance
Stenvers, D. J., Scheer, F. A. J. L., Schrauwen, P., la Fleur, S. E., & Kalsbeek, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0122-1 · Cited by 733 · see citing works
Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome
MYERS, J. N., Kokkinos, P. F., & Nyelin, E. (2019) · Nutrients · doi:10.3390/nu11071652 · Cited by 633 · see citing works
Cardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D., & Mather, K. J. (2017) · Translational research · doi:10.1016/j.trsl.2017.01.001 · Cited by 618 · see citing works
Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M., Morris, P. B., Neumiller, J. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.037 · Cited by 466 · see citing works
Self-citationNeeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463 · see citing works
Self-citationNonalcoholic Fatty Liver Disease and the Heart
Stahl, E. P., Dhindsa, D. S., Lee, S. K., Sandesara, P. B., Chalasani, N., & Sperling, L. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.050 · Cited by 445 · see citing works
Self-citation10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Das, S. R., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s010 · Cited by 339 · see citing works
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., de Heredia, F. P., Davies, I. G., & Stewart, C. E. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 331 · see citing works
Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Cefalu, W. T., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M. L., Morris, P. B., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.020 · Cited by 300 · see citing works
Self-citationNolan, C. J., & Prentki, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827611 · Cited by 292 · see citing works
Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome
Wang, H. H., Lee, D. K., Liu, M., Portincasa, P., & Wang, D. Q. ‐. (2020) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2020.23.3.189 · Cited by 294 · see citing works
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer
Chen, H., Zheng, X., Zong, X., Li, Z., Li, N., Hur, J., Fritz, C. D. L., Chapman, W. C., Nickel, K. B., Tipping, A. D., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321661 · Cited by 230 · see citing works
Zilberter, Y., & Zilberter, M. Y. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24064 · Cited by 213 · see citing works
Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss
Hyde, P. N., Sapper, T. N., Crabtree, C. D., LaFountain, R. A., Bowling, M. L., Buga, A., Fell, B., McSwiney, F. T., Dickerson, R. M., Miller, V. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128308 · Cited by 210 · see citing works
Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials
Chiva‐Blanch, G., & Badimón, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5812401 · Cited by 211 · see citing works
Chew, N., Mehta, A., Goh, R. S. J., Zhang, A. A. Y., Chen, Y., Chong, B., Chew, H. S. J., Shabbir, A., Brown, A. C., Dimitriadis, G. K., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.070535 · Cited by 185 · see citing works
Self-citationNatural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
Waltenberger, B., Mocan, A., Šmejkal, K., Heiß, E. H., & Atanasov, A. G. (2016) · Molecules · doi:10.3390/molecules21060807 · Cited by 177 · see citing works
Mollica, A., Zengin, G., Locatelli, M., Stefanucci, A., Mocan, A., Macedonio, G., Carradori, S., Onaolapo, O. J., Onaolapo, A. Y., Adegoke, J., et al. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.05.001 · Cited by 150 · see citing works
Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration
Jha, S. K., Jha, N. K., Kumar, D., Ambasta, R. K., & Kumar, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.015 · Cited by 122 · see citing works
He, M., Wang, J., Liang, Q., Li, M., Guo, H., Wang, Y., Deji, C., Sui, J., Wang, Y.-W., Liu, Y., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100777 · Cited by 111 · see citing works
Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management
Zhang, Y., & Ren, J. T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.005 · Cited by 109 · see citing works
Monnerie, S., Comte, B., Ziegler, D., Morais, J. A., Pujos‐Guillot, E., & Gaudreau, P. (2020) · Scientific Reports · doi:10.1038/s41598-019-56909-7 · Cited by 109 · see citing works
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States
Minhas, A. M. K., Mathew, R. O., Sperling, L. S., Nambi, V., Virani, S. S., Navaneethan, S. D., Shapiro, M. D., & Abramov, D. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.368 · Cited by 109 · see citing works
Self-citationPirro, M., Mannarino, M. R., Bianconi, V., Simental‐Mendía, L. E., Bagaglia, F., Mannarino, E., & Sahebkar, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.021 · Cited by 104 · see citing works
Stenvers, D. J., Jongejan, A., Atiqi, S., Vreijling, J. P., Limonard, E. J., Endert, E., Baas, F., Moerland, P. D., Fliers, E., Kalsbeek, A., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4813-5 · Cited by 105 · see citing works
Mechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 107 · see citing works
Self-citationTime-Restricted Eating and Metabolic Syndrome: Current Status and Future Perspectives
Świątkiewicz, I., Woźniak, A., & Taub, P. R. (2021) · Nutrients · doi:10.3390/nu13010221 · Cited by 100 · see citing works
Byrne, C. D., Armandi, A., Pellegrinelli, V., Vidal‐Puig, A., & Bugianesi, E. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01045-z · Cited by 109 · see citing works
Eslam, M., Ahmed, A., Després, J., Jha, V., Halford, J. C. G., Chieh, J. T. W., Harris, D. C. H., Nangaku, M., Colagiuri, S., Targher, G., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00132-1 · Cited by 101 · see citing works
Self-citationZiki, M. D. A., & Mani, A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000276 · Cited by 95 · see citing works
Sleep Apnea and Sleep Habits: Relationships with Metabolic Syndrome
Borel, A. (2019) · Nutrients · doi:10.3390/nu11112628 · Cited by 93 · see citing works
Wu, J., Zhang, H. E., Yang, L., Shao, J., Chen, D., Cui, N., Tang, L., Fu, Y., Xue, E., Lai, C., et al. (2022) · Obesity Reviews · doi:10.1111/obr.13510 · Cited by 98 · see citing works
Kuwabara, M., Kuwabara, R., Hisatome, I., Niwa, K., Roncal-Jiménez, C. A., Bjornstad, P., Andrés-Hernando, A., Sato, Y., Jensen, T., García, G., et al. (2017) · Obesity · doi:10.1002/oby.22000 · Cited by 81 · see citing works
DANESHPOUR, M. S., Fallah, M., Sedaghati-khayat, B., Guity, K., Khalili, D., Hedayati, M., Ebrahimi, A., Hajsheikholeslami, F., Mirmiran, P., Tehrani, F. R., et al. (2017) · JMIR Research Protocols · doi:10.2196/resprot.6050 · Cited by 75 · see citing works
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 76 · see citing works
The Role of Oxidative Stress Enhanced by Adiposity in Cardiometabolic Diseases
Świątkiewicz, I., Wróblewski, M., Nuszkiewicz, J., Sutkowy, P., Wróblewska, J., & Woźniak, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076382 · Cited by 79 · see citing works
Borel, A., Coumes, S., Reche, F., Ruckly, S., Pépin, J., Tamisier, R., Wion, N., & Arvieux, C. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206617 · Cited by 74 · see citing works
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001307 · Cited by 75 · see citing works
Self-citationComprehensive Care Models for Cardiometabolic Disease
Reiter–Brennan, C., Dzaye, O. D. A., Davis, D. M., Blaha, M., & Eckel, R. H. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01450-1 · Cited by 71 · see citing works
Kim, H., Chung, J., Kim, K.-J., Kim, H., Seo, W., Jeon, K., Cho, I., Park, J. J., Lee, M., Suh, J., et al. (2021) · Korean Circulation Journal · doi:10.4070/kcj.2021.0328 · Cited by 72 · see citing works
Time-Restricted Eating in Adults With Metabolic Syndrome
Manoogian, E. N. C., Wilkinson, M. J., O'Neal, M. A., Laing, K. L., Nguyen, J. P., Van, D. T., Rosander, A. M., Pazargadi, A., Gutierrez, N. R., Fleischer, J., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m24-0859 · Cited by 69 · see citing works
An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease
Loaeza-Reyes, K. J., Zenteno, E., Rodríguez, A. M., Rosas, R. T., Argueta‐Figueroa, L., Salinas-Marín, R., Castillo-Real, L. M., Pina-Canseco, M. D. S., & Pérez-Cervera, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.751637 · Cited by 67 · see citing works
Strauß, M., Foshag, P., Przybylek, B., Horlitz, M., Lucía, A., Sanchis‐Gomar, F., & Leischik, R. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0174-0 · Cited by 67 · see citing works
Chen, Y., Xu, W. L., Zhang, W., Tong, R., Yuan, A., Li, Z., Jiang, H., Hu, L., Huang, L., Xu, Y., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101109 · Cited by 64 · see citing works
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62 · see citing works
Central and peripheral circadian clocks and their role in Alzheimer's disease
Chauhan, R., Chen, K.-F., Kent, B. A., & Crowther, D. C. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030627 · Cited by 58 · see citing works
“Such outcomes resemble the features of the metabolic syndrome (Sperling et al., 2015), characterized in humans by insulin resistance, abdominal obesity, abnormal lipids and hypertension, which is linked to type II diabetes.”
BackgroundSears, S. C., Buendia, J. R., Odem, S., Qobadi, M., WORTLEY, P. M., Mgbere, O. O., Sanders, J., Spencer, E. C., & Barnes, A. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02487-8 · Cited by 57 · see citing works
Norvik, J. V., Storhaug, H. M., Kirsti Ytrehus, B., Jenssen, T. G., Zykova, S. N., Eriksen, B. O., & Solbu, M. D. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0265-8 · Cited by 57 · see citing works
Dommermuth, R., & Ewing, K. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.10.003 · Cited by 56 · see citing works
The Adipokine-Cardiovascular-Lifestyle Network
Mechanick, J. I., Zhao, S., & Garvey, W. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.072 · Cited by 55 · see citing works
Self-citationMetabolic Syndrome and Cardiovascular Disease: A Health Challenge
González-Chávez, A., Chávez-Fernández, J. A., Elizondo-Argueta, S., González-Tapia, A., León-Pedroza, J. I., & Ochoa, C. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.10.003 · Cited by 56 · see citing works
Saely, C. H., Leiherer, A., Muendlein, A., Vonbank, A., Rein, P., Geiger, K. D., Malin, C., & Drexel, H. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.100 · Cited by 55 · see citing works
Peyter, A., Armengaud, J.-B., Guillot, E., & Yzydorczyk, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136667 · Cited by 52 · see citing works
Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay
Wilkinson, M. J., & Shapiro, M. D. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319983 · Cited by 56 · see citing works
Piantedosi, D., Loria, A. D., Guccione, J., Rosa, A. D., Fabbri, S., Cortese, L., Carta, S., & Ciaramella, P. (2016) · The Veterinary Journal · doi:10.1016/j.tvjl.2016.07.002 · Cited by 52 · see citing works
Cardiovascular and Metabolic Effects of Açaí, an Amazon Plant
de Moura, R. S., & Resende, Â. C. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000347 · Cited by 51 · see citing works
The art of cardiovascular risk assessment
Khambhati, J., Allard‐Ratick, M., Dhindsa, D. S., Lee, S. K., Chen, J. L., Sandesara, P. B., O’Neal, W. T., Quyyumi, A. A., Wong, N. D., Blumenthal, R. S., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.22930 · Cited by 51 · see citing works
Self-citationGerman, C. A., Baum, S. J., Ferdinand, K. C., Gulati, M., Polonsky, T. S., Toth, P. P., & Shapiro, M. D. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100432 · Cited by 53 · see citing works
Tabrizi, R., Ostadmohammadi, V., Lankarani, K. B., Peymani, P., Akbari, M., Kolahdooz, F., & Asemi, Z. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0779-4 · Cited by 51 · see citing works
Poon, E. T., Wongpipit, W., Li, H., Wong, S. H., Siu, P. M., Kong, A. P. S., & Johnson, N. A. (2024) · British Journal of Sports Medicine · doi:10.1136/bjsports-2024-108481 · Cited by 48 · see citing works
11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
Bailey, M. A. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0797-z · Cited by 46 · see citing works
Autophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome
Yang, M., Zhang, Y., & Ren, J. T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00038 · Cited by 45 · see citing works
Nutrition in Type 2 Diabetes and the Metabolic Syndrome
Via, M. A., & Mechanick, J. I. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.06.009 · Cited by 43 · see citing works
Self-citationGibson, R., Eriksen, R., Singh, D., Vergnaud, A., Heard, A., Chan, Q. M., Elliott, P., & Frost, G. S. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1562-4 · Cited by 43 · see citing works
Metabolic syndrome and underlying genetic determinants-A systematic review
Rana, S., Ali, S., Wani, H. A., Mushtaq, Q. D., Sharma, S., & Rehman, M. U. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01009-z · Cited by 49 · see citing works
The Mechanism of Honey in Reversing Metabolic Syndrome
Hashim, K.-N., Chin, K., & Ahmad, F. (2021) · Molecules · doi:10.3390/molecules26040808 · Cited by 41 · see citing works
Iron Reshapes the Gut Microbiome and Host Metabolism
Botta, A. M., Barra, N. G., Lam, N. H., Chow, S., Pantopoulos, K., Schertzer, J. D., & Sweeney, G. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.2.160 · Cited by 39 · see citing works
Kazlauskaite, R., Janssen, İ., Wilson, R. S., Appelhans, B. M., Evans, D. A., Arvanitakis, Z., Khoudary, S. R. E., & Kravitz, H. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa067 · Cited by 40 · see citing works
Wang, Y., Yu, L., Gao, Y., Jiang, L., Yuan, L., Wang, P., Cao, Y., Song, X., Ge, L., & Ding, G. (2021) · Chronobiology International · doi:10.1080/07420528.2020.1797763 · Cited by 40 · see citing works
Wilner, B. R., Garg, S., Ayers, C. R., Maroules, C. D., McColl, R. W., Matulevicius, S. A., de Lemos, J. A., Drazner, M. H., Peshock, R. M., & Neeland, I. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005897 · Cited by 38 · see citing works
Self-citationMetabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study
Neeland, I., Boone, S., Mook-Kanamori, D., Ayers, C., Smit, R., Tzoulaki, I., Karaman, I., Boulangé, C., Vaidya, D., Punjabi, N., et al. (2019) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.118.010810 · Cited by 35 · see citing works
Self-citationHealth disparities in cardiometabolic risk among Black and Hispanic youth in the United States
Katz, S. F., Rodríguez, F., & Knowles, J. W. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100175 · Cited by 38 · see citing works
Nichols, G. A., Horberg, M., Koebnick, C., Young, D. R., Waitzfelder, B., Sherwood, N. E., Daley, M. F., & Ferrara, A. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160438 · Cited by 36 · see citing works
van Greevenbroek, M. M. J., Schalkwijk, C. G., & Stehouwer, C. D. A. (2016) · F1000Research · doi:10.12688/f1000research.8971.1 · Cited by 37 · see citing works
Ladeiras‐Lopes, R., Moreira, H. T., Bettencourt, N., Fontes‐Carvalho, R., Sampaio, F., Ambale‐Venkatesh, B., Wu, C. O., Liu, K., Bertoni, A. G., Ouyang, P., et al. (2018) · Diabetes · doi:10.2337/db17-1496 · Cited by 37 · see citing works
Bourebaba, Y., Mularczyk, M., Marycz, K., & Bourebaba, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111113 · Cited by 37 · see citing works
Teratani, T., Tomita, K., Suzuki, T., Furuhashi, H., Irie, R., Hida, S., Okada, Y., Kurihara, C., Ebinuma, H., Nakamoto, N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.020 · Cited by 36 · see citing works
Ma, W., Wu, W., Wen, W., Xu, F., Han, D., Lyu, J., & Huang, Y. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221122478 · Cited by 36 · see citing works
Vinoy, S., Laville, M., & Feskens, E. J. M. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.31662 · Cited by 35 · see citing works
Zhou, Y., Wu, W., Zou, Y., Huang, W., Lin, S., Ye, J., & Lan, Y. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0589 · Cited by 35 · see citing works
Balzer, M. S., Pavkovic, M., Frederick, J., Abedini, A., Freyberger, A., Vienenkoetter, J., Mathar, I., Siudak, K., Eitner, F., Sandner, P., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100992 · Cited by 33 · see citing works
Metabolic syndrome and smoking are independent risk factors of male idiopathic infertility
the ALIFERT collaborative group, Dupont, C., Faure, C., Daoud, F., Gautier, B., Czernichow, S., & Lévy, R. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0090-x · Cited by 32 · see citing works
Serrablo-Torrejon, I., López‐Valenciano, A., Ayuso, M., Horton, E., Mayo, X., Medina‐Gómez, G., Liguori, G. A., & Jiménez, A. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00640-2 · Cited by 37 · see citing works
Gibson, R., Eriksen, R., Chambers, E., Gao, H., Aresu, M., Heard, A., Chan, Q., Elliott, P., & Frost, G. (2019) · Nutrients · doi:10.3390/nu11081839 · Cited by 31 · see citing works
Logvinov, S. V., Naryzhnaya, N. V., Kurbatov, B. K., Gorbunov, A. S., Birulina, Y. G., Maslov, L., & Oeltgen, P. R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111543 · Cited by 30 · see citing works
The Relationship Between Lycopene and Metabolic Diseases
Kulawik, A., Cielecka‐Piontek, J., Czerny, B., Kamiński, A., & Zalewski, P. (2024) · Nutrients · doi:10.3390/nu16213708 · Cited by 29 · see citing works
Asgedom, Y. S., Melaku, T., Gebrekidan, A. Y., Koyira, M. M., Azeze, G. A., Lombebo, A. A., Efa, A. G., Haile, K. E., & Kassie, G. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-62497-y · Cited by 29 · see citing works
Šatrauskienė, A., Navickas, R., Laucevičius, A., Krilavičius, T., Užupytė, R., Zdanytė, M., Ryliškytė, L., Jucevičienė, A., & Holvoet, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041483 · Cited by 28 · see citing works
Yan, X. S., Mudiganti, S., Husby, H. M., Hudnut, A. G., Gbotoe, M., & Jones, J. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-21916-8 · Cited by 29 · see citing works
Nayiager, T., Anderson, L., Cranston, A., Athale, U. H., & Barr, R. D. (2016) · Quality of Life Research · doi:10.1007/s11136-016-1462-8 · Cited by 26 · see citing works
Short-Term Heart Rate Variability in Metabolic Syndrome: A Systematic Review and Meta-Analysis
Guzmán, J. E. O., Mollà‐Casanova, S., Serra‐Añó, P., Arias-Mutis, O. J., Calvo, C. J., Bizy, A., Alberola, A. M., Chorro, F. J., & Zarzoso, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186051 · Cited by 31 · see citing works
Pahk, K., Kim, E. J., Joung, C., Seo, H. S., & Kim, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01115-3 · Cited by 25 · see citing works
2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis
Gyldenkerne, C., Kahlert, J. A., Thrane, P. G., Olesen, K. K. W., Mortensen, M. B., Sørensen, H. T., Thomsen, R. W., & Mæng, M. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.050 · Cited by 25 · see citing works
Etchecopar‐Etchart, D., Mignon, R., Boyer, L., & Fond, G. B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01593-9 · Cited by 24 · see citing works
Pilot Clinical Trial of Time-Restricted Eating in Patients with Metabolic Syndrome
Świątkiewicz, I., Mila-Kierzenkowska, C., Woźniak, A., Szewczyk‐Golec, K., Nuszkiewicz, J., Wróblewska, J., Rajewski, P., Eussen, S. J. P. M., Færch, K., Manoogian, E. N. C., et al. (2021) · Nutrients · doi:10.3390/nu13020346 · Cited by 23 · see citing works
Robinson, M. D., Mishra, I., Deodhar, S., Patel, V., Gordon, K. V., Vintimilla, R., Brown, K., Johnson, L. A., O’Bryant, S. E., & Cistola, D. P. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1359-5 · Cited by 23 · see citing works
Keleszade, E., Patterson, M., Trangmar, S. J., Guinan, K. J., & Costabile, A. (2021) · Molecules · doi:10.3390/molecules26030714 · Cited by 24 · see citing works
Weng, L., Gong, Y., Culver, J. A., Gardell, S. J., Petucci, C. J., Morse, A. M., Frye, R. F., Turner, S. T., Chapman, A. B., Boerwinkle, E., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1098-2 · Cited by 22 · see citing works
- Authors
- Sperling, L. S., Mechanick, J. I., Neeland, I. J., Herrick, C. J., Després, J.-P., Ndumele, C. E., Vijayaraghavan, K., Handelsman, Y., Puckrein, G. A., Araneta, M. R. G., Blum, Q. K., Collins, K. K., Cook, S., Dhurandhar, N. V., Dixon, D. L., Egan, B. M., Ferdinand, D. P., Herman, L. M., Hessen, S. E., Jacobson, T. A., Pate, R. R., Ratner, R. E., Brinton, E. A., Forker, A. D., Ritzenthaler, L. L., & Grundy, S. M.
- Affiliations
- Emory University (US)
- Icahn School of Medicine at Mount Sinai (US)
- The University of Texas Southwestern Medical Center (US)
- Washington University in St. Louis (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Johns Hopkins University (US)
- National Quality Forum (US)
- University of California San Diego (US)
- Inova Fairfax Hospital (US)
- American Academy of Pediatrics (US)
- Texas Tech University (US)
- Virginia Commonwealth University (US)
- University of South Carolina (US)
- New York Institute of Technology (US)
- University of Pennsylvania (US)
- American Diabetes Association (US)
- Foundation for Biomedical Research (US)
- University of Missouri–Kansas City (US)
- American College of Cardiology (US)
- Corresponding author
- Sperling, Laurence S.
- ORCID
- Sperling, Laurence S.
- Mechanick, Jeffrey I.
- Neeland, Ian J.
- Herrick, Cynthia J.
- Després, Jean-Pierre
- Ndumele, Chiadi E.
- Vijayaraghavan, Krishnaswami
- Handelsman, Yehuda
- Puckrein, Gary A.
- Araneta, Maria Rosario G.
- Collins, Karen K.
- Cook, Stephen
- Dhurandhar, Nikhil V.
- Dixon, Dave L.
- Egan, Brent M.
- Ferdinand, Daphne P.
- Herman, Lawrence M.
- Jacobson, Terry A.
- Pate, Russell R.
- Brinton, Eliot A.
- Grundy, Scott M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 66
- Issue
- 9
- Pages
- 1050-1067
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1152644542
- Cited by
- 294
- References
- 109
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 38 · 2023: 30 · 2022: 28 · 2021: 33 · 2020: 27 · 2019: 28 · 2018: 21 · 2017: 21 · 2016: 25 · 2015: 2
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Keywords
- metabolic syndrome, cardiometabolic risk, patient care model, metabolic syndrome prevention, metabolic syndrome risk factors, consensus development
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, District of Columbia, Health Promotion, Humans, Hypertension, Models, Cardiovascular, Obesity, Societies, Medical, Survival Analysis, Treatment Outcome, Evidence-Based Medicine, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review